Results 241 to 250 of about 21,036 (302)

Efficacy of advanced Fenton-photo systems for the degradation of petroleum hydrocarbons using complex neural networks. [PDF]

open access: yesRSC Adv
Ashkanani Z   +9 more
europepmc   +1 more source

Real‐world evidence supports the safety and efficacy profile of luspatercept in clinically complex and heavily iron‐overloaded patients

open access: yes
British Journal of Haematology, EarlyView.
Barbara Gianesin   +29 more
wiley   +1 more source

Chemical and Functional Consistency of Condensed Tannins from <i>Anadenanthera macrocarpa</i> at Different Collection Sites. [PDF]

open access: yesACS Omega
Silva KVRA   +6 more
europepmc   +1 more source

Polymeric Nanoparticles with Surface-Anchored Functional Groups as Chelating Agents for Calcium (Ca<sup>2+</sup>) and Magnesium (Mg<sup>2+</sup>) Ions to Inhibit Cellular Interactions. [PDF]

open access: yesPharmaceuticals (Basel)
Ruiz-Virgen L   +10 more
europepmc   +1 more source

Iron-Chelating Agents in Non-Iron Overload Conditions

Annals of Internal Medicine, 1994
To review the current clinical experience with iron chelators in non-iron overload conditions.The English-language literature was searched from 1983 through 1992 manually and using MEDLINE.Original articles, case reports, and abstracts addressing iron chelation.Selected reports that described clinical applications of iron chelators in non-iron overload
E E, Voest, G, Vreugdenhil, J J, Marx
openaire   +2 more sources

Iron chelators as therapeutic iron depletion agents

Expert Opinion on Therapeutic Patents, 2006
The great promise of iron depletion as a therapeutic strategy for various diseases, including iron overload, cancers, Alzheimer’s disease, Parkinson’s disease, tuberculosis, HIV, and fungal and malaria infection, has stimulated research on the development of iron chelators as iron depletion agents.
Noah Birch, Xiang Wang, Hyun-Soon Chong
openaire   +1 more source

Home - About - Disclaimer - Privacy